1. Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab
   Mehmet Asim Bilen et al, 2018, Clinical Genitourinary Cancer CrossRef
2. Predictive factors of nivolumab plus ipilimumab treatment efficacy in metastatic renal cell carcinoma patients
   Kojiro Ohba et al, 2024, Japanese Journal of Clinical Oncology CrossRef
3. Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101
   Y. Tomita et al, 2022, ESMO Open CrossRef
4. Development of a prognostic composite cytokine signature based on the correlation with nivolumab clearance: translational PK/PD analysis in patients with renal cell carcinoma
   Rui Wang et al, 2019, Journal for ImmunoTherapy of Cancer CrossRef